OTC · Drug Manufacturers - Specialty & Generic

C21 Investments Inc. (CXXIF) Stock

$0.21 -3.53% OTC: CXXIF Healthcare

C21 Investments Inc. operates as a fully integrated cannabis enterprise, overseeing the cultivation, processing, distribution, and retail sale of cannabis and hemp-derived consumer goods throughout the United States.

Valuation

MetricValue
Price$0.21
Market Cap$24.33M
P/E Ratio-9.40
P/B Ratio1.76
P/S Ratio0.75
EPS (TTM)$-0.03
52-Week High$0.54
52-Week Low$0.19
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-11.98%
ROA-5.83%
ROCE4.65%
Gross Margin39.13%
Operating Margin6.99%
Net Margin-9.91%
Debt/Equity0.41
Current Ratio1.30

Annual Financials (USD)

Metric20222023202420252026
Revenue$33.0M$29.0M$28.0M$30.0M$32.0M
Operating Profit$10.0M$4.0M$1.0M$1.0M$2.0M
Net Profit$10.0M$0$-3.0M$-4.0M$-3.0M
EPS$0.09$0.01$-0.03$-0.03$-0.03
Op Margin29.6%13.7%5.2%4.3%7.0%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$62.0M$58.0M$55.0M$57.0M$55.0M
Total Liabilities$27.0M$24.0M$23.0M$28.0M$28.0M
Cash$3.0M$2.0M$2.0M$3.0M$2.0M
Borrowings$19.0M$12.0M$11.0M$13.0M$11.0M

Latest News

Vireo Growth Inc. and C21 Investments Inc. Announce Definitive Arrangement Agreement CNW Group · Jun 15, 2026 C21 Investments Reports Fourth Quarter and Fiscal Year End Financial Results CNW Group · Jun 11, 2026 Top 3 TSX Penny Stocks With Market Caps Over CA$40M To Watch Simply Wall St. · May 21, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$7.0M$6.0M$5.0M$1.0M$1.0M
Investing Cash Flow$-4.0M$-1.0M$0$-7.0M$0
Financing Cash Flow$-1.0M$-1.0M$-1.0M$-1.0M$0
Net Cash Flow$-3.0M$-1.0M$-1.0M$-1.0M$0
Free Cash Flow$4.0M$5.0M$5.0M$-3.0M$1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.22
EV / EBITDA7.58
FCF Yield4.54%
Quick Ratio0.58
Interest Coverage4.06
Return 1Y-0.97%
Return 3Y-26.79%
Return 5Y—

Ownership

Insiders Held12.32%
Institutions Held5.51%
Institutions Float Held6.28%
Institutional HolderSharesReport Date
AdvisorShares Trust-AdvisorShares Pure US Cannabis ETF18,141,8572026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CANSFAtlas Energy Corp. $0.09 +0.00% -2.10 $30.64M 0.00%
DXBRFBellRock Brands Inc. $0.00 — 0.00 $53153 0.00%
ELIXFElixxer Ltd. $0.03 +0.00% -0.14 $23.35M 0.00%
FLOOFFlower One Holdings Inc. $0.00 — -0.03 $4731 0.00%
MILFF1CM Inc. $0.10 +0.00% 3.27 $12.06M 0.00%

About C21 Investments Inc.

C21 Investments Inc. operates as a fully integrated cannabis enterprise, overseeing the cultivation, processing, distribution, and retail sale of cannabis and hemp-derived consumer goods throughout the United States. Its diverse product line features pre-packaged and bulk flower, vape cartridges, concentrated extracts, ingestible items, pre-rolled joints, liquid tinctures, and topical applications. Beyond its core cannabis business, the company also provides payroll and benefits administration services. Founded in 1987, C21 Investments Inc. maintains its corporate headquarters in Vancouver, Canada. The company was formerly known as Curlew Lake Resources Inc. until it adopted its current name in November 2017.

C21 Investments Inc. is headquartered in CA.

C21 Investments Inc. (CXXIF) stock trades at $0.21 with a market capitalization of $24.33M. The stock is valued at a price-to-earnings (P/E) ratio of -9.40, price-to-book of 1.76, price-to-sales of 0.75. Over the past 52 weeks the stock has ranged between $0.19 and $0.54, and currently trades 61.1% below its 52-week high.

On profitability, C21 Investments Inc. generates a return on equity (ROE) of -11.98%, return on capital employed of 4.65%, an operating margin of 6.99%, a net profit margin of -9.91%.

Official website: www.cxxi.ca

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides